問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

王俊隆
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2022-11-01 - 2025-01-07

Phase III

Completed
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)
  • Condition/Disease

    Idiopathic Pulmonary Fibrosis

  • Test Drug

    BI 1015550

Participate Sites
8Sites

Not yet recruiting8Sites